Citation: | Chi Ma, Dandan Zhu, Yu Chen, Yiwen Dong, Wenyi Lin, Ning Li, Wenjie Zhang, Xiaoxuan Liu. Amphiphilic peptide dendrimer-based nanovehicles for safe and effective siRNA delivery[J]. Biophysics Reports, 2020, 6(6): 278-289. doi: 10.1007/s41048-020-00120-z |
(2020) Second RNAi drug approved. Nat Biotechnol 38:385
|
Bajan S, Hutvagner G (2020) RNA-based therapeutics:from antisense oligonucleotides to miRNAs. Cells 9(1):137. https://doi.org/10.3390/cells9010137
|
Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A, De Montis MG, Tagliamonte A, Neri P (2003) Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem 278(47):46590-46595
|
Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNAinterference-based therapeutics. Nature 457(7228):426-433
|
Chen C, Posocco P, Liu X, Cheng Q, Laurini E, Zhou J, Liu C, Wang Y, Tang J, Col VD, Yu T, Giorgio S, Fermeglia M, Qu F, Liang Z, Rossi JJ, Liu M, Rocchi P, Pricl S, Peng L (2016) Mastering dendrimer self-assembly for efficient siRNA delivery:from conceptual design to in vivo efficient gene silencing. Small 12(27):3667-3676
|
Crespo L, Sanclimens G, Pons M, Giralt E, Royo M, Albericio F (2005) Peptide and amide bond-containing dendrimers. Chem Rev 105(5):1663-1681
|
Darbre T, Reymond JL (2006) Peptide dendrimers as artificial enzymes, receptors, and drug-delivery agents. Acc Chem Res 39(12):925-934
|
Dong Y, Chen Y, Zhu D, Shi K, Ma C, Zhang W, Rocchi P, Jiang L, Liu X (2020) Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy. J Control Release 322:416-425
|
Dong Y, Yu T, Ding L, Laurini E, Huang Y, Zhang M, Weng Y, Lin S, Chen P, Marson D, Jiang Y, Giorgio S, Pricl S, Liu X, Rocchi P, Peng L (2018) A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy. J Am Chem Soc 140(47):16264-16274
|
Heitz M, Javor S, Darbre T, Reymond JL (2019) Stereoselective pH responsive peptide dendrimers for siRNA transfection. Bioconjug Chem 30(8):2165-2182
|
Inoue Y, Kurihara R, Tsuchida A, Hasegawa M, Nagashima T, Mori T, Niidome T, Katayama Y, Okitsu O (2008) Efficient delivery of siRNA using dendritic poly (L-lysine) for loss-of-function analysis. J Control Release 126(1):59-66
|
Juliano RL (2016) The delivery of therapeutic oligonucleotides. Nucleic Acids Res 44(14):6518-6548
|
Kanasty R, Dorkin JR, Vegas A, Anderson D (2013) Delivery materials for siRNA therapeutics. Nat Mater 12(11):967-977
|
Kay RF (2015) Drugging RNAi. Science 347(6226):1068-1069
|
Kesharwani P, Jain K, Jain NK (2014) Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 39(2):268-307
|
Khandare J, Calderon M, Dagia NM, Haag R (2012) Multifunctional dendritic polymers in nanomedicine:opportunities and challenges. Chem Soc Rev 41(7):2824-2848
|
Kim B, Park JH, Sailor MJ (2019) Rekindling RNAi therapy:materials design requirements for in vivo siRNA delivery. Adv Mater 31(49):e1903637. https://doi.org/10.1002/adma.201903637
|
Ledford H (2018) Gene-silencing technology gets first drug approval after 20-year wait. Nature 560(7718):291-292
|
Lee CC, MacKay JA, Frechet JM, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23(12):1517-1526
|
Li Y, Bai H, Wang H, Shen Y, Tang G, Ping Y (2018) Reactive oxygen species (ROS)-responsive nanomedicine for RNAi-based cancer therapy. Nanoscale 10(1):203-214
|
Liu X, Liu C, Zhou J, Chen C, Qu F, Rossi JJ, Rocchi P, Peng L (2015) Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer. Nanoscale 7(9):3867-3875
|
Liu X, Wang Y, Chen C, Tintaru A, Cao Y, Liu J, Ziarelli F, Tang J, Guo H, Rosas R, Giorgio S, Charles L, Rocchi P, Peng L (2016) A fluorinated bola-amphiphilic dendrimer for on-demand delivery of siRNA, via specific response to reactive oxygen species. Adv Func Mater 26(47):8594-8603
|
Liu X, Zhou J, Yu T, Chen C, Cheng Q, Sengupta K, Huang Y, Li H, Liu C, Wang Y, Posocco P, Wang M, Cui Q, Giorgio S, Fermeglia M, Qu F, Pricl S, Shi Y, Liang Z, Rocchi P, Rossi JJ, Peng L (2014) Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems. Angew Chem Int Ed Engl 53(44):11822-11827
|
Luo K, Li C, Li L, She W, Wang G, Gu Z (2012) Arginine functionalized peptide dendrimers as potential gene delivery vehicles. Biomaterials 33(19):4917-4927
|
Malhotra S, Bauer H, Tschiche A, Staedtler AM, Mohr A, Calderon M, Parmar VS, Hoeke L, Sharbati S, Einspanier R, Haag R (2012) Glycine-terminated dendritic amphiphiles for nonviral gene delivery. Biomacromol 13(10):3087-3098
|
Mintzer MA, Grinstaff MW (2011) Biomedical applications of dendrimers:a tutorial. Chem Soc Rev 40(1):173-190
|
Mullard A (2020) RNAi agents score an approval and drive an acquisition. Nat Rev Drug Discov 19(1):10-10
|
Ozpolat B, Sood AK, Lopez-Berestein G (2014) Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev 66:110-116
|
Percec V, Wilson DA, Leowanawat P, Wilson CJ, Hughes AD, Kaucher MS, Hammer DA, Levine DH, Kim AJ, Bates FS, Davis KP, Lodge TP, Klein ML, DeVane RH, Aqad E, Rosen BM, Argintaru AO, Sienkowska MJ, Rissanen K, Nummelin S, Ropponen J (2010) Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science 328(5981):1009-1014
|
Rocchi P, So A, Kojima S, Signaevsky M, Beraldi E, Fazli L, HurtadoColl A, Yamanaka K, Gleave M (2004) Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res 64(18):6595-6602
|
Sadler K, Tam JP (2002) Peptide dendrimers:applications and synthesis. J Biotechnol 90(3-4):195-229
|
Sapra R, Verma RP, Maurya GP, Dhawan S, Babu J, Haridas V (2019) Designer peptide and protein dendrimers:a cross-sectional analysis. Chem Rev 119(21):11391-11441
|
Setten RL, Rossi JJ, Han SP (2019) The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov 18(6):421-446
|
Svenson S, Tomalia D (2005) Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 57(15):2106-2129
|
Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98(20):10983-10985
|
Wagner E (2012) Polymers for siRNA delivery:inspired by viruses to be targeted, dynamic, and precise. Acc Chem Res 45(7):1005-1013
|
Weng Y, Xiao H, Zhang J, Liang X-J, Huang Y (2019) RNAi therapeutic and its innovative biotechnological evolution. Biotechnol Adv 37(5):801-825
|
Whitehead KA, Langer R, Anderson DG (2009) Knocking down barriers:advances in siRNA delivery. Nat Rev Drug Discov 8(2):129-138
|
Wittrup A, Lieberman J (2015) Knocking down disease:a progress report on siRNA therapeutics. Nat Rev Genet 16(9):543-552
|
Wu M, Liu X, Jin W, Li Y, Li Y, Hu Q, Chu PK, Tang G, Ping Y (2017) Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy. J Control Release 253:110-121
|
Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15(8):541-555
|
Yu T, Liu X, Bolcato-Bellemin AL, Wang Y, Liu C, Erbacher P, Qu F, Rocchi P, Behr JP, Peng L (2012) An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo. Angew Chem Int Ed Engl 51(34):8478-8484
|